Trial started· ClinicalTrials.gov
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
LY4065967 History and Updates
15 events · 2024 – present
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
0
FDA Approvals
0
Label Revisions
15
Trial Milestones
0
Pivotal Publications
Source: openFDA, ClinicalTrials.gov via AACT, PubMed · Hipa.ai, 2026-06-12Download chart as PNG
This page tracks every FDA action, clinical trial milestone, and major publication for LY4065967 since 2024, drawn from openFDA, ClinicalTrials.gov, and PubMed.
Upcoming & expected milestones
Trial started· ClinicalTrials.gov
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
Primary completion· ClinicalTrials.gov
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Primary completion· ClinicalTrials.gov
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
Primary completion· ClinicalTrials.gov
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Past events
2026
Trial registered· ClinicalTrials.gov
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Trial registered· ClinicalTrials.gov
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
Trial started· ClinicalTrials.gov
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
2025
Trial registered· ClinicalTrials.gov
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Primary completion· ClinicalTrials.gov
A Study of [14C]-LY4065967 in Healthy Participants
Trial registered· ClinicalTrials.gov
A Study of [14C]-LY4065967 in Healthy Participants
Trial started· ClinicalTrials.gov
A Study of [14C]-LY4065967 in Healthy Participants
Primary completion· ClinicalTrials.gov
A Study of LY4065967 in Healthy Japanese Participants
2024
Trial started· ClinicalTrials.gov
A Study of LY4065967 in Healthy Japanese Participants
Trial registered· ClinicalTrials.gov
A Study of LY4065967 in Healthy Japanese Participants
Sources
FDA approvals, label revisions, and recalls come from the public openFDA APIs (Drugs@FDA, Drug Label, Drug Enforcement). Drug-safety communications come from the FDA RSS feed. Trial milestones come from ClinicalTrials.gov via the AACT pg dump. Pivotal-publication events come from PubMed, filtered to high-impact journals linked to a Phase 3 trial in our inventory.